Mariah Jensen-Wachspress

SARS-CoV-2–specific T cells are rapidly expanded for therapeutic use and target conserved regions of the membrane protein

Michael D. Keller, Katherine M. Harris, Mariah Jensen-Wachspress et al. · Blood · 2020 · 139 citations · Full text

Life Sciences, Immunology, Infectious Diseases +8

Robust Antibody and T Cell Responses to SARS-CoV-2 in Patients with Antibody Deficiency

Hannah Kinoshita, Jessica Durkee-Shock, Mariah Jensen-Wachspress et al. · Journal of Clinical Immunology · 2021 · 58 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16

Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II interventional trial of pediatric patients with risk factor assessment

Michael D. Keller, Patrick J. Hanley, Yueh‐Yun Chi et al. · Nature Communications · 2024 · 25 citations · Full text

Life Sciences, Hematology, Immunology +17

SARS-CoV-2-Specific T Cell Responses Are Stronger in Children With Multisystem Inflammatory Syndrome Compared to Children With Uncomplicated SARS-CoV-2 Infection

Susan R. Conway, Christopher A. Lazarski, Naomi E. Field et al. · Frontiers in Immunology · 2022 · 23 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Transcriptomic analysis reveals optimal cytokine combinations for SARS-CoV-2-specific T cell therapy products

Jessica Durkee-Shock, Christopher A. Lazarski, Mariah Jensen-Wachspress et al. · Molecular Therapy — Methods & Clinical Development · 2022 · 10 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16